| Product Code: ETC6737826 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to import baricitinib primarily from the USA, India, Japan, Germany, and Belgium. Despite the low concentration of the Herfindahl-Hirschman Index (HHI), indicating a diverse import market, the compound annual growth rate (CAGR) for baricitinib imports from 2020 to 2024 was negative at -7.29%. Furthermore, there was a significant decline in growth rate from 2023 to 2024 at -13.39%, reflecting potential challenges or shifts in the market dynamics for this pharmaceutical product in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Baricitinib Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Baricitinib Market Revenues & Volume, 2021 & 2031F |
3.3 China Baricitinib Market - Industry Life Cycle |
3.4 China Baricitinib Market - Porter's Five Forces |
3.5 China Baricitinib Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Baricitinib Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
3.7 China Baricitinib Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Baricitinib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rheumatoid arthritis and other autoimmune diseases in China |
4.2.2 Growing adoption of innovative therapies in the healthcare sector |
4.2.3 Government initiatives to improve access to advanced treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High cost associated with baricitinib treatment |
4.3.3 Limited awareness and education about baricitinib among healthcare professionals and patients |
5 China Baricitinib Market Trends |
6 China Baricitinib Market, By Types |
6.1 China Baricitinib Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Baricitinib Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Baricitinib Market Revenues & Volume, By DMARDs, 2021- 2031F |
6.1.4 China Baricitinib Market Revenues & Volume, By JAK Inhibitors, 2021- 2031F |
6.2 China Baricitinib Market, By End- Users |
6.2.1 Overview and Analysis |
6.2.2 China Baricitinib Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 China Baricitinib Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 China Baricitinib Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 China Baricitinib Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.2.6 China Baricitinib Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Baricitinib Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Baricitinib Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 China Baricitinib Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 China Baricitinib Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Baricitinib Market Import-Export Trade Statistics |
7.1 China Baricitinib Market Export to Major Countries |
7.2 China Baricitinib Market Imports from Major Countries |
8 China Baricitinib Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on baricitinib in China |
8.2 Percentage of rheumatologists prescribing baricitinib as a treatment option |
8.3 Patient adherence rate to baricitinib therapy |
8.4 Number of partnerships and collaborations between pharmaceutical companies for the development and distribution of baricitinib in China |
8.5 Rate of adverse events reported related to baricitinib use in China |
9 China Baricitinib Market - Opportunity Assessment |
9.1 China Baricitinib Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Baricitinib Market Opportunity Assessment, By End- Users, 2021 & 2031F |
9.3 China Baricitinib Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Baricitinib Market - Competitive Landscape |
10.1 China Baricitinib Market Revenue Share, By Companies, 2024 |
10.2 China Baricitinib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |